Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment-Reference-Cited by-同舟云学术

Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment

Published:2021-12-18 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Dawson John C.¹^ORCID,Munro Alison¹,Macleod Kenneth¹,Muir Morwenna¹,Timpson Paul²^ORCID,Williams Robert J.³,Frame Margaret¹,Brunton Valerie G.¹,Carragher Neil O.¹^ORCID

Affiliation:

1. Cancer Research UK Edinburgh Centre Institute of Genetics and Cancer University of Edinburgh Edinburgh UK

2. Cancer Theme The Kinghorn Cancer Centre Garvan Institute of Medical Research Sydney Australia

3. Cancer Research UK Centre for Drug Development London UK

Funder

Cancer Research UK

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13151

Reference69 articles.

1. Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology

2. Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications

3. A renaissance for SRC

4. The Role of Src in Solid Tumors

5. c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities;Bioorganic Chemistry;2024-01

2. Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors;International Review of Cell and Molecular Biology;2024

3. Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells;Cell Death & Disease;2023-11-08

4. Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo;PLOS ONE;2023-03-23

5. KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration;Journal of Clinical Medicine;2023-01-16